Mechanisms of dormancy, activation and sexual conversion in pre-erythrocytic malaria parasites

The DEXES project aims to uncover the molecular mechanisms of Plasmodium liver infection outcomes influenced by host metabolism to inform new malaria treatment strategies.

Subsidie
€ 2.000.000
2023

Projectdetails

Introduction

Malaria remains a devastating public health burden – the estimated death toll in 2020 was over 600,000. Its eradication is a desirable goal; however, the development of novel intervention strategies is hampered by limited current understanding of the biology of Plasmodium, the causative agent of malaria, and of its complex interactions with mammalian and mosquito hosts.

Plasmodium Life Cycle

In the liver, inside hepatocytes, Plasmodium parasites can either:

  1. Replicate, forming new parasites that will infect erythrocytes and cause disease, or
  2. Remain dormant, which can lead to chronic, relapsing disease weeks to years after the original infection.

I recently discovered new hepatic outcomes using a novel pipeline for single-cell hepatocyte-pathogen sequencing. I have identified sub-populations of sexually committed parasite forms, previously thought to appear only during erythrocytic infection. This groundbreaking insight into the Plasmodium life cycle can change our understanding of malaria transmission. Yet, it remains unknown how malaria parasites commit to these different developmental outcomes in hepatocytes.

Research Hypothesis

DEXES will test the hypothesis that Plasmodium liver infection outcomes depend upon the metabolic state of the host hepatocyte. Using engineered human microlivers, new humanized mouse models, trans-species studies, and single-cell technologies, I will:

  1. Identify parasite-encoded molecular mechanisms implicated in the induction and maintenance of dormancy, activation, and sexual conversion in the liver, and
  2. Establish the bidirectional relationships between host metabolism and distinct parasite cell fates and their impact on treatment outcomes.

Project Goals

This project will uncover the molecular mechanisms underpinning dormancy, relapsing, and transmission of malaria parasites, and lay the groundwork for the future development of new therapies targeting the liver infection reservoirs.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.000.000
Totale projectbegroting€ 2.000.000

Tijdlijn

Startdatum1-10-2023
Einddatum30-9-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEpenvoerder
  • INSTITUT PASTEUR

Land(en)

France

Vergelijkbare projecten binnen European Research Council

ERC Synergy ...

Parasite-host interactions regulating dormancy and reactivation of malaria parasites

This project aims to investigate the dormancy and reactivation of malaria hypnozoites using multidisciplinary methods to uncover insights for new therapeutic strategies against malaria.

€ 11.429.675
ERC Advanced...

Plasmodium liver stage schizogony: high replication and genetic diversity

This project aims to uncover the mechanisms behind Plasmodium's high replication rate during liver infection, linking it to genetic diversity and malaria severity to inform new intervention strategies.

€ 2.467.196
ERC Starting...

Revival of the Powerhouse: How mitochondrial remodelling controls the energy metabolism of the malaria parasite to enable survival in different hosts

This project aims to elucidate the structure and function of Plasmodium falciparum mitochondria to inform antimalarial drug discovery by using advanced structural and functional techniques.

€ 1.499.408
ERC Consolid...

The malaria chemical atlas: Revealing the parasite-host functional interactome

The MalChemAtlas project aims to uncover the chemical communication of the malaria parasite Plasmodium falciparum to develop novel interventions against malaria.

€ 2.000.000
ERC Starting...

Cell cycle progression in malaria parasites

The JANUS project aims to unravel the unique cell cycle mechanisms of Plasmodium falciparum through transcriptomics and proteomics, enhancing understanding of malaria pathogenesis and potential treatments.

€ 1.499.928